Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Budach

Showing results (121-130 of 133) with videos related to

Pageof 14
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 28, 2005
Adjuvant chemoradiation using 5-fluorouracil/folinic acid/cisplatin with or without paclitaxel and radiation in patients with completely resected high-risk gastric cancer: two cooperative phase II studies of the AIO/ARO/ACOC Kollmannsberger, W Budach, M Stahl, et al.
Deutsche Medizinische Wochenschrift (1946)|October 20, 2011
[Multimodal therapy in locally advanced gastric cancer]E Bölke, M Peiper, W T Knoefel, et al.
European Journal of Medical Research|October 26, 2011
Trimodal therapy in squamous cell carcinoma of the esophagusC Matuschek, E Bölke, T Zahra, et al.
European Journal of Medical Research|June 22, 2010
Evaluation of the tissue toxicity of antiseptics by the hen's egg test on the chorioallantoic membrane (HETCAM)C Marquardt, E Matuschek, E Bölke, et al.
European Journal of Medical Research|April 6, 2011
Dendritic cell generation and CD4+ CD25high FOXP3+ regulatory t cells in human head and neck carcinoma during radio-chemotherapyPatrick J Schuler, V Börger, E Bölke, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|January 9, 2025
Implant-based reconstruction and adjuvant radiotherapy in breast cancer patients-current status and DEGRO recommendationsM D Piroth, D Krug, R Baumann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 11, 2018
Neoadjuvant chemotherapy followed by chemoradiation and surgery with and without cetuximab in patients with resectable esophageal cancer: a randomized, open-label, phase III trial (SAKK 75/08)T Ruhstaller, P Thuss-Patience, S Hayoz, et al.
European Journal of Medical Research|October 26, 2011
Do insulin-like growth factor associated proteins qualify as a tumor marker? Results of a prospective study in 163 cancer patientsC Matuschek, M Rudoy, M Peiper, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|August 11, 2012
Long-term outcome after neoadjuvant radiochemotherapy in locally advanced noninflammatory breast cancer and predictive factors for a pathologic complete remission : results of a multivariate analysisC Matuschek, E Bölke, S L Roth, et al.
Bone Marrow Transplantation|September 4, 2003
A new conditioning regimen involving total marrow irradiation, busulfan and cyclophosphamide followed by autologous PBSCT in patients with advanced multiple myelomaH Einsele, M Bamberg, W Budach, et al.
Pageof 14

Showing results (121-130 of 133) with videos related to

Sort By:
Pageof 14
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 28, 2005
Adjuvant chemoradiation using 5-fluorouracil/folinic acid/cisplatin with or without paclitaxel and radiation in patients with completely resected high-risk gastric cancer: two cooperative phase II studies of the AIO/ARO/ACOC Kollmannsberger, W Budach, M Stahl, et al.
Deutsche Medizinische Wochenschrift (1946)|October 20, 2011
[Multimodal therapy in locally advanced gastric cancer]E Bölke, M Peiper, W T Knoefel, et al.
European Journal of Medical Research|October 26, 2011
Trimodal therapy in squamous cell carcinoma of the esophagusC Matuschek, E Bölke, T Zahra, et al.
European Journal of Medical Research|June 22, 2010
Evaluation of the tissue toxicity of antiseptics by the hen's egg test on the chorioallantoic membrane (HETCAM)C Marquardt, E Matuschek, E Bölke, et al.
European Journal of Medical Research|April 6, 2011
Dendritic cell generation and CD4+ CD25high FOXP3+ regulatory t cells in human head and neck carcinoma during radio-chemotherapyPatrick J Schuler, V Börger, E Bölke, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|January 9, 2025
Implant-based reconstruction and adjuvant radiotherapy in breast cancer patients-current status and DEGRO recommendationsM D Piroth, D Krug, R Baumann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 11, 2018
Neoadjuvant chemotherapy followed by chemoradiation and surgery with and without cetuximab in patients with resectable esophageal cancer: a randomized, open-label, phase III trial (SAKK 75/08)T Ruhstaller, P Thuss-Patience, S Hayoz, et al.
European Journal of Medical Research|October 26, 2011
Do insulin-like growth factor associated proteins qualify as a tumor marker? Results of a prospective study in 163 cancer patientsC Matuschek, M Rudoy, M Peiper, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|August 11, 2012
Long-term outcome after neoadjuvant radiochemotherapy in locally advanced noninflammatory breast cancer and predictive factors for a pathologic complete remission : results of a multivariate analysisC Matuschek, E Bölke, S L Roth, et al.
Bone Marrow Transplantation|September 4, 2003
A new conditioning regimen involving total marrow irradiation, busulfan and cyclophosphamide followed by autologous PBSCT in patients with advanced multiple myelomaH Einsele, M Bamberg, W Budach, et al.
Pageof 14